Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Tavapadon as Adjunctive Treatment for Parkinson Disease: The TEMPO-3 Randomized Clinical Trial.
Journal: JAMA neurology
Published: March 20, 2026
Long-term real-world effectiveness of carbidopa/levodopa enteral suspension after 36 months of treatment initiation in advanced Parkinson's disease in the US: final results from the PROviDE study.
Journal: Clinical parkinsonism & related disorders
Published: February 23, 2026
Practices and perceptions around splitting of carbidopa/levodopa tablets: a survey of patients and neurologists.
Journal: Neurodegenerative disease management
Published: December 03, 2025
Opicapone in Parkinson's patients with motor fluctuations: clinical assessments and patient-reported outcomes from the OPTI-ON study.
Journal: Clinical parkinsonism & related disorders
Published: November 06, 2025
Transcutaneous Peripheral Nerve Stimulation for Essential Tremor: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: October 20, 2025
Underlying Tremor Improvement with Consistent Use of Transcutaneous Afferent Patterned Stimulation in Patients with Essential Tremor.
Journal: Tremor and other hyperkinetic movements (New York, N.Y.)
Published: September 13, 2025
Cutaneous Phosphorylated Alpha-Synuclein in Lewy Body Dementia.
Journal: Annals of clinical and translational neurology
Published: September 12, 2025
Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: August 05, 2025
The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.
Journal: Nature aging
Published: June 30, 2025
Efficacy and Safety of Foslevodopa/Foscarbidopa Monotherapy in Patients with Parkinson's Disease.
Journal: Movement disorders clinical practice
Published: April 07, 2025
Management of Parkinson's disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switching.
Journal: Expert opinion on pharmacotherapy
Published: March 26, 2025
Safety and Efficacy of Istradefylline in Parkinson's Disease Patients With and Without Preexisting Dyskinesia: Pooled Analysis of 8 Randomized Controlled Trials.
Journal: Journal of movement disorders
Published: February 27, 2025
Last Updated: 09/26/2026